TyraTech acquired by American Vanguard Corp.

TyraTech, Inc. (AIM: TYR), a publicly-traded AIM market life sciences company focused on nature-derived insect and parasite control products, merged with American Vanguard Corp. (NYSE: AVD). Prior to the transaction, American Vanguard held approximately 35% of the shares of Tyratech. The transaction included de-listing of Tyratech shares from the AIM market.

Waller served as lead counsel to TyraTech in the transaction.

For additional information, see media coverage here.

Related Experience

Summit BHC acquires Peak View Behavioral Health

Represented Summit Behavioral Healthcare in its acquisition of Colorado-based Peak View Behavioral Health.

Cloudscale365, Inc. acquires all stock of Georgia-based Strategic Systems Consulting, Inc.

Represented Cloudscale365, Inc. as transaction counsel during their acqusition of all the stock of Georgia-based Strategic Systems Consulting, Inc., a similar email exchange and cloud based hosting services company.

CareBridge launches operations to improve care to patients receiving long-term support services

Assisted CareBridge in the acquisitions of HealthStar and Sinq Technologies, and its $35 million investment from Oak HC/FT, Google Ventures (GV) and other strategic investors.

View More